BRIEF published on 04/09/2025 at 14:44, 1 year 5 months ago Amundi Physical Metals plc: UK Final Terms Financial Markets Gold ETC Securities Issuance Investment Program Amundi Metals
BRIEF published on 04/09/2025 at 14:44, 1 year 5 months ago Amundi Physical Metals plc : Conditions définitives pour le Royaume-Uni Marchés Financiers Or ETC Émission De Titres Programme D'investissement Amundi Metals
BRIEF published on 04/09/2025 at 14:37, 1 year 5 months ago Fabrice Heyriès nommé Directeur général d'AG2R LA MONDIALE Stratégie Assurance Nomination AG2R LA MONDIALE Fabrice Heyriès
BRIEF published on 04/09/2025 at 14:37, 1 year 5 months ago Fabrice Heyriès appointed Managing Director of AG2R LA MONDIALE Insurance Appointment Strategy AG2R LA MONDIALE Fabrice Heyriès
BRIEF published on 04/09/2025 at 14:35, 1 year 5 months ago Aspire Biopharma Initiates Phase 1 Trial for High-Dose Aspirin Phase 1 Trial FDA Fast Track Aspire Biopharma High-dose Aspirin Sublingual Formulation
BRIEF published on 04/09/2025 at 14:35, 1 year 5 months ago Aspire Biopharma lance un essai de phase 1 pour l'aspirine à haute dose Procédure Accélérée De La FDA Essai De Phase 1 Aspire Biopharma Aspirine À Haute Dose Formulation Sublinguale
BRIEF published on 04/09/2025 at 14:24, 1 year 5 months ago Amundi Physical Metals: Final Terms for Gold ETC Securities Euronext Amundi Gold ETC Final Terms Tranche 679
BRIEF published on 04/09/2025 at 14:24, 1 year 5 months ago Amundi Physical Metals : Conditions définitives pour les titres ETC Gold Euronext Amundi Or ETC Conditions Définitives Tranche 679
BRIEF published on 04/09/2025 at 14:20, 1 year 5 months ago Revolve Renewable Power Corp. Achieves Key Developments in Q1 2025 Renewable Energy Revenue Growth North America Expansion Corporate Development Project Acquisition
BRIEF published on 04/09/2025 at 14:20, 1 year 5 months ago Revolve Renewable Power Corp. réalise des avancées clés au premier trimestre 2025 Énergie Renouvelable Croissance Des Revenus Développement De L'entreprise Expansion En Amérique Du Nord Acquisition De Projet
Published on 09/12/2026 at 02:35, 14 hours 36 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 18 hours 11 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 19 hours 6 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 19 hours 46 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 9 hours 40 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 18 hours 56 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 19 hours 1 minute ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 21 hours 26 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 22 hours 56 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 10 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 10 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 21 hours ago Availability of the 2026 Interim Financial Report
